IPO plans for magic-mushroom-holding: How good is the new project of German investor Christian Angermayer? | Handelsblatt 10.06.2021 – Quotes by FCF
On Thursday, June 10, the German newspaper “Handelsblatt” reported online and in its print version on the planned IPO of ATAI Life Sciences, a German company specializing in psychedelic drugs. Previously labeled as narcotic drugs,
FCF MedTech & Diagnostics Public Equity Monitor – May 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF MedTech & Diagnostics Public Equity Monitor – May 2021”. The MedTech & Diagnostics Public Equity Monitor, part of FCF Life Sciences Research Series,
FCF Life Sciences Venture Capital Monitor – Europe 04/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 04/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Industrial Machinery Market Study – 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Industrial Machinery Market Study – 2021”. Based on available data from European industrial machinery producers, the FCF Industrial Machinery Market Study is a
FCF Life Sciences SPAC Monitor – 05/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences SPAC Monitor – 05/2021”. The Monitor is a quarterly published overview focusing on the performance of life sciences companies after the
FCF Life Sciences: Cool off for SPAC-Boom
Number of SPAC IPOs has stagnated since April Potential reason could be a Statement from U.S. Securities and Exchange Commission (SEC) 611 SPAC IPOs since May 2020 Munich, May 18, 2021 – The boom around
FCF Valuation Monitor – Q1 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q1 2021”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
Boom in biotech venture capital financing
Financing volume in the USA doubled in the first quarter of 2021 High growth also in Europe Munich, May 05, 2021 – The boom in biotech venture capital financing continues: In the US, the venture
FCF Biotech Venture Capital Monitor – USA 04/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 04/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences in the Börse Online magazine | 19. April 2021
FCF Life Sciences in the Börse Online magazine | 19. April 2021 The Life Sciences team at FCF Fox Corporate Finance has recently published an analysis on Special Purpose Acquisition Companies (SPACs) with a focus